Introduction
We postulated that vascular phosphoinositide metabolism is attenuated during pregnancy, and thereby could contribute to maternal vasodilation and reduced vascular reactivity. The basal rate of incorporation of '3Himyo-inositol and VHjglycerol into phosphoinositides ofaortae from pregnant rats in vitro was significantly reduced, when compared with vessels from virgin animals. After injection of [Hjmyo-inositol intravenously into chronically instrumented conscious pregnant and virgin rats, the incorporation of the label by phosphatidylinositol was 66±4% less in aortae of gravid versus virgin animals (P < 0.001), despite comparable plasma concentrations ofradioactivity. Fold stimulation of total 13Hlinositol phosphates by arginine vasopressin, norepinephrine, and angiotensin II over a 15-min period was not different between aortic segments from virgin and gravid rats, although both absolute basal and stimulated levels were significantly less in vessels from pregnant animals. After 45 s of incubation with 10' M arginine vasopressin, however, the fold-stimulation of VHlinositol trisplus tetrakisphosphate was reduced in aortae from gravid rats, when compared with vessels from virgin animals (P < 0.005). By HPLC, > 90% of the radioactivity in the 13Hlinositol trisplus tetrakisphosphate column fraction after 30 and 60 s of agonist stimulation was VHlinositol-1,4,5-trisphosphate. We further observed that the rate of uptake of [Hjmyo-inositol by aortic vasculature obtained from gravid rats was significantly (24%) less than uptake by vessels from virgin animals. Plasma myo-inositol concentrations were not significantly different, but presumably as a consequence of reduced uptake, aortic segments freshly isolated from pregnant rats contained 22±6% less myo-inositol than vessels from virgin controls as measured by gas chromatography-mass spectrometry (P < 0.03). We conclude that myo-inositol uptake and content, phosphoinositide turnover, and inositol phosphate production are reduced in aortic vasculature of gravid rats. (J. Clin. Invest. 1991. 87:1700-1709.) Key words: vasodilation * vascular reactivity . norepinephrine* arginine vasopressin Vasodilation ofthe maternal circulation is a constant feature of normal human pregnancy. Cardiac output, renal blood flow, and glomerular filtration rate increase by 30 to 60% (1-3) while blood pressure declines (4, 5) . Furthermore, pressor response to administration ofangiotensin II (6) and vascular reactivity to infusion of norepinephrine (7) become attenuated. Insight into the mechanisms responsible for these phenomena may be particularly critical because attenuation of vascular responses to angiotensin II and norepinephrine as well as systemic and renal vasodilation are lost in women who develop preeclampsia (6) (7) (8) (9) .
We have found that the chronically instrumented, conscious rat manifests alterations in renal and cardiovascular function during gestation, which are remarkably similar to those observed in normal gravid women (10) (11) (12) (13) . Thus, the pregnant rat may be a useful animal model in which to investigate mechanism(s) responsible for maternal vasodilation and attenuated vascular reactivity to vasoconstrictor hormones. Since blood vessels of gravid rats (14) (15) (16) (17) (18) (19) (20) , rabbits (21) , cats (21) , and guinea pigs (22) demonstrate decreased vascular reactivity in vitro or in situ, it seems likely that alterations within the vasculature itself are important. Vasoconstrictor receptor desensitization during pregnancy does not appear to account for the refactory vascular response, at least to angiotensin II and arginine vasopressin (23) (24) (25) (26) . (The density and affinity of alpha,-adrenergic receptors on vascular smooth muscle have not been evaluated during pregnancy.) Although controversial, vasodilatory prostaglandins may not be involved in the vasodilation and attenuated vascular reactivity of pregnancy either (1 1, 22, 27) . A possible role for cyclic guanosine-3',5'-monophosphate and endothelium-derived relaxing factor has been recently suggested (12, 28, 29) . Alternatively, we postulated that intracellular processes which mediate vasoconstriction may be altered during gestation such that vasodilation and reduced vascular reactivity occur. As a first step, we examined phosphoinositide turnover, an early event in the signal transducing pathway, which is critical to vascular smooth muscle contraction (30, 31) . The results support the view that phosphoinositide turnover, inositol phosphate production, and myo-inositol uptake are significantly attenuated in aortic vasculature of gravid rats. Similar changes in resistance vessels may contribute to vasodilation or to reduced vascular reactivity during pregnancy.
sue was used in order to obtain sufficient mass of vasculature to yield detectable signals. On the day of study, agravid (gestational day [18] [19] [20] [21] and virgin rat were killed, and the aortae removed and placed in medium (370C, pH 7.4) preequilibrated with 95% 02/5% CO2. After removal of fat and branching vessels, the aortae were gently perfused to remove residual blood. They were then cut into segments with a sharp razor blade. The endothelium was not removed. The isolation procedure lasted no more than 10 min.
Total water-soluble [3H]inositol phosphates. Aortic segments of 0.5-1.0cm in length were incubated at 370C in 1.5 ml Earle's Balanced Salt Solution (EBSS)' +25 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, pH 7.4, which contained 6 MCi/ml [3Hlmyo-inositol (15 Ci/mmol; American Radiolabeled Chemicals, Inc., St. Louis, MO).
The medium was saturated with 95% 02/5% CO2 and fresh atmosphere was introduced into the vials every 30 min. After incubation for 1, 2,3, or 4 h, the tissues were washed with 2.0 ml ice-cold medium (X5). Next, the aortic segments were incubated for 10 min at 370C in EBSS + 25 mM Hepes, pH 7.4, which contained 10 mM LiCi. LiCl was used to inhibit breakdown of inositol phosphate(s), thus allowing for their accumulation (mainly inositol monophosphate) in order to facilitate detection by scintillation counting. Agonist (norepinephrine, angiotensin II, arginine vasopressin) or vehicle (0.9% saline or medium) was added for a further 15-min incubation. Tissues were homogenized in 1.0 ml 0.6 N HCI04 (4°C). The homogenates were centrifuged at 3,200 g for 10 min and the supernatant neutralized with -120 Ml 5.0 N KOH. After another centrifugation step to pellet the KC104, the supernatant was added to 9.0 ml 5 mM disodium tetraborate. The samples were applied to anion exchange columns (32) (Dowex AG1-X8; Bio-Rad, Richmond, CA). Myo-inositol and glycerophosphoinositol were eluted with two to three successive applications of 10-12 ml each of 60 mM sodium formate/5 mM disodium tetraborate. Total water-soluble [3H]inositol phosphates (mainly inositol monophosphate) were eluted at once with 12 ml 1.0 M ammonium formate/0.1 M formic acid. Duplicate 500-microliter aliquots were counted in 10 ml scintillation fluid (formula 963; New England Nuclear, Boston, MA) for 20 min each (model LS 3801; Beckman Instruments, Inc., Wakefield, MA). In preliminary experiments (n = 3), the 60 mM sodium formate/5 mM disodium tetraborate effectively removed [3H]myo-inositol that failed to come through in the sample void. This solution, however, did not Aortic segments of0.5-1.0 cm in length were incubated at 37°C in 1.5 ml EBSS + 20 mM Hepes, pH 7.4, which contained 10 MCi/ml [3H]-myo-inositol. The medium was saturated with 95% 02/5% CO2 and fresh atmosphere was introduced into the vials every 30 min. After incubation for 3 h, the tissue was washed with 1.5 ml ice-cold medium (x5). Aortic segments were then transferred to fresh medium at 37°C (without LiCl), and vehicle or I07 M arginine vasopressin was added for the indicated times (up to 2 min). Tissues were homogenized in 1.0 ml 0.6 N HCI04 (4°C) which contained phytic acid hydrolysate (-26 Mg phosphorus) (33) . The homogenates were centrifuged at 3,200 g for 10 min and the supernatant was neutralized with 1.25 ml freon/tri-noctylamine (1:1 vol/vol). After vortexing each sample for I min, the phases were separated by centrifugation at 2,000g for 5 min. The upper phase was then transferred to a graduated tube, and distilled water was added to produce a final volume of 4 ml.
Individual water soluble inositol phosphates were separated by Accell QMA Sep-Pak column chromatography (Waters Associates, Milford, MA) (adapted and modified from reference 33). After application of the sample to the Sep-Pak column, the following reagents were pushed through (10 ml/min): distilled water (5 ml X 3), 5 mM Na2B4O7 (5 Phosphoinositides, in vitro labeling. Aortic segments of 1.0 cm in length were incubated in 6 MCi/ml [3H]myo-inositol (0.47 MM) for 1, 2, 3, or 4 h as described above. They were then washed five times with 2.0 ml ice-cold medium, and homogenized in 2.0 ml chilled CHC13:CH30H: concentrated HCI (200:100:1) and 0.4 ml distilled water. After centrifugation at 1325 g for 5 min to separate the phases, the lower chloroform layer which contained lipids was transferred to a 5.0-ml conical vial (Wheaton Instruments, Millville, NJ). The protein was extracted again with fresh solvent. The lower phase was then combined with the first and stored under N2 at -40°C. The following day, after removal of a residual aqueous layer, the organic phase was dried (Savant Speedvac Concentrator, Savant Instruments, Inc., Farmingdale, NY or N-Evap; Organomation, South Berlin, MA). Unlabeled phospholipid standards were added to the residue: 25 MAg phosphatidylinositol-4,5-bisphosphate, 15 Mg lysophosphatidylinositol, 10 Mg phosphatidylinositol4-phosphate, and 10 MAg phosphatidylinositol (Sigma Chemical Co., St. Louis, MO). The sides of the vials were washed with an additional 0.5 ml of the acidified extraction mixture, and after drying, the residue was resuspended in 100 MI CHC13:CH3OH:H20-37.5:12.5:1, and sonicated for 5 min (Branson Co., Shelton, CT). Thin layer plates coated with Silica Gel H + 1% potassium oxalate (Analtec Inc., Newark, DE) were activated for 30 min at 1 10°C. Samples were applied in 1.0-cm lanes, and 50 Mul CHC13:CH30H:H20 was again added to each vial, and then applied to the TLC plates. Lipids were separated by a moving phase ofCHC13:CH30H:4 M NH40H 45:35:10 (34). The spots were visualized with iodine vapor, and after sublimation, scraped into 10 ml scintillation fluid (formula 963; New England Nuclear) and each counted for 20 min.
In several experiments, tissues were labeled with [3H]myo-inositol in medium which contained concentrations of myo-inositol (Sigma Chemical Co.) within the physiological range. That is, unlabeled myoinositol was added to the incubation medium to achieve a final concentration of 50 MM. In some experiments Ham's F12:Eagles Minimum Essential Medium (1:1; Hazelton Systems, Inc., Denver, PA) was used instead of EBSS. The myo-inositol concentration of this mixture was 55 gM.
Additional experiments were conducted using ['Higlycerol as a precursor (New England Nuclear). Aortic segments of 1.0 cm length were incubated in EBSS + 20 mM Hepes, saturated with 95% 0215% CO2, pH 7.4, which contained 50 MM myo-inositol (MI), 100 AM glycerol, and 6 MCi/ml ['H]glycerol. Three aortic segments were used from each animal. One ofthe segments was incubated for 1.5 h, a second segment for 3.0 h, and a third also for 3.0 h. The third segment, however, was also incubated with 1 MM norepinephrine during the last 1.5 h of incubation. The tissues were then thoroughly washed in ice-cold medium (X5). Phospholipids were extracted and separated by TLC, and counted as described above. Because phosphatidylinositol and phosphatidylserine comigrate in the TLC system previously described, they were scraped from the plate, extracted from the gel, applied to another TLC plate, and separated by a moving phase of CHCI3:CH3OH:CH3-COOH:H2O (81:10:45:1) (35).
Phosphoinositides, in vivo labeling. Midpregnant and age-matched virgin rats were chronically instrumented with a femoral venous catheter using aseptic technique (1 1). 5-7 d later, the animals were administered [3H]myo-inositol intravenously in a total volume of 250 Ml 0.9% saline. Gravid and virgin rats received 43 MCi/275 g and 50 MCi/275 g body weight, respectively. The catheter was then flushed with an additional 1.0 ml of0.9% saline. Blood (-50 Ml) was drawn at 5, 15, 30, 60, and 120 min after the injection of ['H]myo-inositol, and after centrifugation the plasma was counted for radioactivity (10 Ml in duplicate). At 120 min, the rats were administered 40 mg/kg i.v. pentobarbital. A laparotomy was quickly performed. The animal was killed by rapidly withdrawing 10-20 cc of blood from the abdominal aorta. The aorta was then removed and placed in ice-cold medium. It was next cleaned, perfused, and cut into two 2.0-cm segments. These segments were thoroughly washed in ice-cold medium (X5), subjected to organic extraction, and the phospholipids separated by TLC and counted as described above.
Myo-inositol uptake. Aortic segments were preincubated for Plasma concentration ofmyoinositol, enzymatic-fluorometric assay (adapted and modifiedfrom references 36 and 37). 500 MA ofplasma was chilled on ice and treated with 500 MI of ice-cold 0.6 N HC104 for 15 min. The mixture was vortexed every 5 min and the precipitated proteins were pelleted by centrifugation. The supernatant was then treated with 5.0 N KOH until the pH was 7.0. After another centrifugation step, the volume was set to 1.0 ml by tare, and 200 Ml in triplicate was assayed for MI, and an additional 200-Ml aliquot served as a blank. In order to destroy endogenous glucose, 20 Ml of 0.1 N NaOH was added and the samples were heated for 20 min at 75°C. After cooling to room temperature, endogenous NADH was destroyed by addition of 20 Ml 1.6 N HCL. After a 10 min incubation, 1,600 M of50 mM Na2CO3, pH 9.5, was added to each sample, followed by 200 Ml of enzyme mixture. The enzyme mixture was freshly prepared and consisted of 0.24% bovine serum albumin, 0.5 U/ml myo-inositol dehydrogenase, and 6 mM NAD in 50 mM Na2CO3 (all from Sigma Chemical Co.). For the blank, BSA and NAD were added, but not myo-inositol dehydrogenase. Myoinositol standards were prepared in a final volume of200 Ml and ranged from 0 to 12 nmol. Fluoroescence was read at 1 h by which time the reaction had proceeded to completion. Excitation and emission wavelengths were 340 and 482 nm, respectively.
Gas chromatography-mass spectrometry (adapted and modified from references 38 and 39). A 1.0-ml sample of chilled plasma was treated with 1.0 ml ofice-cold 10% HC104 for 15 min. The mixture was vortexed every 5 min and the precipitated proteins pelleted by centrifugation. The supernatant was then treated with 5.0 N KOH until the pH was 7.0. After another centrifugation step, the supernatant was transferred to a 5.0-ml Wheaton vial and 12,500 ng ofalpha-methyl-D-mannopyranoside was added as an internal standard (Aldrich Chemical Co., Milwaukee, WI). The mixture was dried down in a savant Speedvac concentrator (2 h at 450C). The sides were then scraped with a small metal spatula, and 250 M1 of trimethylsilating reagent was added (4.25 ml pyridine, 500 Ml hexamethyldisilazane, and 250 /l trimethylchlorosilane; Aldrich Chemical Co.). After vortexing and sonication, the samples were allowed to incubate for 1 h at room temperature before a final centrifugation step. Standards containing 20, 50, and 100 ng/Ml of myo-inositol and of alpha-methyl-D-mannopyranoside were run and yielded a linear relationship. A standard containing 50 ng/Ml of myo-inositol and of alpha-methyl-D-mannopyranoside was processed concurrently with each batch of four to six samples. In this way a "relative response factor" of myo-inositol compared with the internal standard could be calculated, and subsequently used to determine the amount of myo-inositol in the sample. A Finnigan MAT (San Jose, CA) 4000 gas chromatography-mass spectrometry (GC/MS) system was used. The GC was a Finnigan model 9610 (Econocap SE-54 column, 30 meter X 0.25 mm inside diameter from Alltech Associates, Inc., Avondale, PA). Electron-impact ionization was employed. The sensitivity of the assay was 1 ng.
Aortic content ofMI. 2-cm segments of freshly isolated aorta were thoroughly washed in ice-cold buffer free of myo-inositol. They were then homogenized in 1.0 ml 0.6 N HC104 and the supernatant neutralized with 5 N KOH. Myo-inositol content was measured by GC/MS as previously described for plasma.
Analytical procedure. Aortic protein was determined by the technique of Lowry et al. (40) (Fig. 4, A-D (Fig. 6 A) . (Because endogenous plasma myo-inositol concentration was not significantly different between gravid * Mean±SEM. The data from which these ratios were generated are displayed in Table I . No significant differences were observed between virgin and pregnant rats in the fold stimulation exerted by vasoconstrictors. $ The original data were expressed as cpm/mg aortic wet weight. 11 The original data were expressed as cpm/mg aortic protein (see Table I ).
and virgin rats, either (see below), the plasma specific activity was also comparable.) Uptake of [3H]myo-inositol was only detectable in lysophosphatidylinositol and phosphatidylinositol, the two most abundant phosphoinositides (Fig. 6 B) . Compared with aortic segments from virgin rats, those from gravid animals incorporated 82±1 1% and 66±4% less label into lysophosphatidylinositol and phosphatidylinositol, respectively.
Myo-inositol uptake. The rate of uptake of [3H]myoinositol by aortic vasculature from pregnant rats was 24% less than [3H]myo-inositol uptake by vessels from virgin animals, when medium myo-inositol was 50 ,gM (Fig. 7 A) . Uptake of
[3H]myo-inositol was completely inhibited in vessels from both virgin and pregnant rats by removing K+ from the medium (Fig. 7 B) Aortic content ofmyo-inositol. Using GC/MS, the myo-inositol content of aortic segments from virgin (n = 9) and gravid (n = 8) rats was 6.6±0.5 and 4.9±0.5 nmol/mg protein, respectively (P < 0.03). Compared with vessels from virgin animals, myo-inositol content was reduced by 22±6% in vessels from gravid rats.
Discussion
Vasodilation of the maternal circulation and attenuation of systemic pressor responsiveness are persistent features of normal human pregnancy. Chronically instrumented, conscious rats also manifest these physiological alterations during pregnancy (10-13). Therefore, the gravid rat may be a useful animal model in which to investigate mechanisms responsible for We first examined the production of total [3H]inositol phosphates in the presence of 10 mM LiCl as an index ofphosphoinositide hydrolysis. Because basal production was altered virgin in vessels from gravid animals (see below), hormone-stimu---* pregnant lated data were factored by basal values ("fold stimulation").
The fold stimulation by maximal doses of angiotensin II, arginine vasopressin, and norepinephrine was not significantly different between aortae from gravid and virgin rats (Table II) . I_ ,* Moreover, the dose-response curves for arginine vasopressin obtained in vessels from both groups of animals were similar (see Results). These data suggest that activation of phospholi-3'0 ' 4'0 * 5'0 pase C by vasoconstrictors is similar in aortae from pregnant and virgin rats. However, insofar as these experiments were imber conducted over a 15-min (41) investigaphosphate was significantly less in vessels from gravid rats (P ture of gravid rats ex-< 0.005 vs. virgin; Fig. 2 Aictor administration in aortae ofgravid rats ( Fig. 1 and Table I ). This finding could raluate the hypothesis result from reduced labeling of phosphoinositides with [3H]-ns that mediate vasomyo-inositol (Fig. 4, A-D phospholipids was uniformly observed, whether the medium in which tissues were incubated contained 0.49 ,uM myo-inositol or a more physiologic concentration of 50 uM, and whether the medium used was a simple balanced salt solution or a cellculture mixture (Table IV) . When in vivo labeling experiments were performed in chronically instrumented conscious rats, significant reductions in incorporation of [3H]myo-inositol into phosphoinositides were again found in vessels from gravid animals (Fig. 6 ). Possible explanations for diminished labeling of aortic phosphoinositides in gravid rats include: (a) attenuated cellular uptake of [3H]myo-inositol, and (b) decreased turnover of phosphoinositides. Decreased mass ofphosphoinositides could also contribute to reduced [3H]myo-inositol incorporation. Before it can be incorporated into phosphoinositides, [3H]myoinositol must first be transported into cells. Our results suggest that the mechanism of uptake in freshly isolated rat aorta is a Na+-cotransport process, insofar as [3H]myo-inositol uptake was completely inhibited in a K+-free medium or by 1 mM ouabain (see Results and Fig. 7 B) . A Na+-cotransport mechanism for myo-inositol uptake has been reported for other tissues (reviewed in reference 43). We further observed that the rate of uptake of [3Hlmyo-inositol into vessels from gravid rats was 24% less than uptake by vessels from virgin animals (Fig. 7 A). Although reduced cellular uptake of [3H]myo-inositol undoubtedly contributed to deficient labeling of phosphoinositides, this explanation alone cannot account for the diminished labeling because the rate of incorporation of [3H]myo-inositol into phosphoinositides was reduced by a greater extent, approximately 50% (Fig. 4 and Table IV) .
These results are compatible with the view that the turnover of phosphoinositides is attenuated in aortae ofgravid rats. The fact that, in addition to reduced incorporation of [3H]myoinositol, the uptake of [3H]glycerol into phosphatidylinositol (Fig. 5 A; but not into phosphatidylserine, Fig. 5 B) was also compromised, further supports the idea that phosphoinositide turnover is attenuated in vessels from gravid rats. Comparatively less incorporation of [3H]glycerol persisted even when uptake into phosphatidylinositol was stimulated by norepinephrine (Fig. 5 A) .
In aortic vasculature from gravid rats, it is possible that reduced cellular uptake of myo-inositol limits the availability of intracellular myo-inositol for optimal synthesis of phosphatidylinositol. Consequently, basal as well as hormone-stimu- 10 of aortic segments obtained from virgin and gravid rats (n = 9 rats°i n each group). Three aortic segments were used from each animal. One of the segments was incubated with 6 2.5 IACi/ml [3H]glycerol for 1.5 h, a second segment 2.0 for 3.0 h, and a third ' 5 also for 3.0 h. The third 1.0 segment, however, was .5 exposed to 1 gM nor-0 epinephrine (NE) during the last 1.5 h of incubation. Medium concentrations of myo-inositol and glycerol were 50 and 100 uM, respectively. After loading of the aortic tissues, they were thoroughly washed, and phospholipids were extracted and separated by thin layer chromatography as described in Methods. Statistics were performed by two-factor ANOVA; the P value given in the figure indicates that overall, incorporation of [3H]glycerol into phosphatidylinositol was significantly less in aortae from gravid rats when compared with that in vessels from virgin controls. lated turnover of phosphoinositides could be compromised. Indeed, measurement of aortic myo-inositol content by GC/ MS demonstrated that vessels from pregnant rats contained 22±6% less myo-inositol (see Results). Because the Km for myo-inositol CDP-diacylglycerol: inositol phosphatidyltransferase may be quite high, -4.6 mM (43), any reduction of intracellular myo-inositol could compromise synthesis of phosphatidylinositol and, thus, ofpolyphosphoinositides. Interestingly, the concept that reduced availability of myo-inositol could compromise phosphatidylinositol biosynthesis has been invoked to explain the change in phospholipid content of surfactant during lung maturation (44, 45) , the neuropathy ofdiabetes (46) , the salutory effect of Li' in affective disorders (47, 48) , as well as the accumulation of triacylglycerol in liver and intestinal lipodystrophy which occur with deficiency ofdietary inositol (reviewed in reference 43).
The mechanism of reduced myo-inositol uptake by aortic vasculature ofgravid rats is unknown. We considered the possibility that elevated plasma levels could downregulate the transporter. However, two independent methods of measurement failed to reveal significant differences in plasma myo-inositol concentrations between virgin and pregnant rats (see Results).
In addition to alterations ofthe Km or V.. ofthe Na/myo-inositol cotransporter, differences in Na/K ATPase activity could be responsible. Indeed, increased levels of circulating digitalislike natriuretic factor have been reported in pregnancy (49) . It would be of interest to determine if the defect in myo-inositol uptake that we observed is specific to vasculature, and whether other substances that undergo Na'-cotransport are also affected.
In summary, we have acquired evidence for attenuation of myo-inositol uptake, phosphoinositide turnover, and inositol Significantly less incorporation of the label was observed in aortic phosphoinositides of pregnant animals (unpaired t tests).
phosphate production in aortic vasculature ofrats during pregnancy. If these alterations also occur in resistance vessels, they could contribute to vasodilation and/or attenuated pressor responsiveness of pregnancy. A unifying theory is that reduced myo-inositol uptake is limiting intracellular availability of myo-inositol for optimal synthesis ofphosphatidylinositol and, consequently, ofpolyphosphoinositides. On this basis, both basal and hormone-stimulated turnover of phosphoinositides and production of inositol phosphates could be compromised.
On the other hand, multiple defects may be operative, e.g., alteration of G-protein function, activity of phospholipase C, or of other enzymes in the signal transduction pathway. In the absence of K+ (B), little or no uptake was detected in aortae from either virgin or pregnant animals. biochemical alterations observed in vasculature of pregnant rats.
